Governance Guardant Health, Inc.

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
78.60 ^USD	-9.83%		-16.23%	-23.05%

03-30	Guardant Health's Infinityai real-world evidence supports approval of Enhertu® for previously treated patients with HER2-positive metastatic solid tumors in Japan	RE
03-30	Guardant Health?s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan	CI

Executive Committee: Guardant Health, Inc.

Manager

Positions heldSince

AmirAli Talasaz

46 year

Chief Executive Officer	04/08/2021
Founder	31/12/2011

Craig Eagle

59 year

Chief Tech/Sci/R&D Officer

02/05/2021

Andrew Ament

Chief Operating Officer

Darya Chudova

52 year

Chief Tech/Sci/R&D Officer

31/07/2015

Michael Bell

57 year

Director of Finance/CFO

04/01/2021

Terilyn Monroe

59 year

Human Resources Officer

01/01/2024

Darl S. Moreland

67 year

General Counsel

Kumud Kalia

60 year

Chief Tech/Sci/R&D Officer

20/01/2020

John Saia

53 year

General Counsel	30/04/2020
Corporate Secretary	30/04/2020

Gulshan H. Shaver

Compliance Officer

30/04/2023

Helmy Eltoukhy

47 year

Chief Executive Officer	31/12/2012
Founder	31/12/2012

Zarak Khurshid

Investor Relations Contact

Composition of the Board of Directors: Guardant Health, Inc.

Director

CommitteesSince

Helmy Eltoukhy

47 year

Chairman

04/08/2021

Ian Clark

65 year

Compensation Committee	31/12/2018
Governance Committee	02/01/2017
Nominating Committee	02/01/2017
Governance Committee Chair	31/07/2020
Nominating Committee Chair	31/07/2020
Audit Committee	31/07/2025

Roberto Mignone

54 year

Finance Committee
Nominating Committee
Audit Committee	20/10/2024
Governance Committee
Finance Committee Chair

Vijaya Gadde

51 year

Compensation Committee Chair	30/04/2022
Compensation Committee	06/12/2021
Governance Committee Chair	06/12/2021
Nominating Committee Chair	06/12/2021

Myrtle Potter

67 year

Compensation Committee	30/04/2022
Governance Committee Chair	31/07/2018
Nominating Committee Chair	31/07/2018
Audit Committee	14/10/2021

Meghan Joyce

42 year

Audit Committee	03/08/2021
Governance Committee Chair	30/04/2020
Nominating Committee Chair	30/04/2020
Compensation Committee	03/08/2021

Alex Michael Azar

58 year

Governance Committee	11/09/2025
Nominating Committee	11/09/2025

Steve Krognes

57 year

Audit Committee	02/06/2025
Audit Committee Chair	12/06/2024

Musa Tariq

43 year

Governance Committee	05/03/2023
Nominating Committee	05/03/2023

Manuel Medina

58 year

Governance Committee	16/07/2024
Nominating Committee	16/07/2024

AmirAli Talasaz

46 year

Compensation Committee Chair

09/08/2021

Latest Appointments: Guardant Health, Inc.

15/09/25	Guardant Health, Inc. Appoints Alex M. Azar II to Its Board of Directors and Nominating and Corporate Governance Committee of the Board, Effective September 12, 2025	CI
24/10/24	Guardant Health, Inc. Appoints Roberto Mignone. as Class I Director	CI
18/07/24	Guardant Health, Inc. Announces the Appointment of Dr. Manuel Hidalgo Medina to Board of Directors	CI
11/07/24	GoodRx Holdings, Inc. Announces the Election of Ian T. Clark to its Board of Directors	CI
13/06/24	Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors and Chairperson of Audit Committee	CI
01/02/24	Guardant Health, Inc. Announces Resignation of Mr. Samir Kaul as Member of the Board and as Member of the Compensation Committee of the Board	CI
02/01/24	Guardant Health Names Terilyn Juarez Monroe as Chief People Officer	MT

More news

Former Officers and Directors: Guardant Health, Inc.

Insider

Positions held

SinceUntil

Steven Collora

Sales & Marketing

30/06/2014

31/05/2024

Amelia Merrill

Human Resources Officer

30/04/2017

30/04/2024

Samir Kaul

Director/Board Member	31/03/2014	31/01/2024
Independent Dir/Board Member	31/03/2014	31/01/2024

Ines Dahne-Steuber

Chief Operating Officer

02/05/2023

09/11/2023

Bill Getty

Corporate Officer/Principal	-	30/10/2023
Sales & Marketing	31/03/2017	-

Michele Rest

Public Communications Contact

31/01/2023

Bahija Jallal

Director/Board Member	16/04/2019	14/06/2022
Independent Dir/Board Member	16/04/2019	14/06/2022

Stanley Meresman

Director/Board Member	30/04/2018	14/06/2022
Independent Dir/Board Member	30/04/2018	14/06/2022

Daniel Simon

Corporate Officer/Principal

31/12/2014

31/12/2021

James Azzaro

Sales & Marketing

31/12/2016

31/12/2020

Derek A. Bertocci

Director of Finance/CFO

30/06/2016

03/12/2020

Dipchand Nishar

Director/Board Member	02/10/2018	11/06/2020
Independent Dir/Board Member	02/10/2018	11/06/2020

Richard B. Lanman

Chief Tech/Sci/R&D Officer

31/08/2014

30/12/2019

Leena Das-Young

Corporate Officer/Principal

31/05/2018

17/06/2019

Aaref Hilaly

Director/Board Member	31/03/2015	31/12/2018
Independent Dir/Board Member	31/03/2015	31/12/2018

Natasha Kehimkar

Corporate Officer/Principal

31/12/2014

31/12/2016

Morteza Minaee

General Counsel

06/05/2015

Bahram Kermani

Corporate Officer/Principal

31/12/2013

Sandra Finley

Sales & Marketing

31/12/2013

Michael Wiley

Director of Finance/CFO	31/12/2012	30/06/2016
Founder	31/12/2011	-
General Counsel	30/06/2016	-
Corporate Officer/Principal	-	-
President	30/06/2012	31/12/2012

Carrie Mendivil

Public Communications Contact

Gary Yeung

Private Equity Investor

Anna Czene

Public Communications Contact

Jiang Bian

Corporate Officer/Principal

Warren H. Hogarth

Director/Board Member

Alex Kleban

Investor Relations Contact

Padma Sundar

Sales & Marketing

Age distribution of managers

Parity Men Women

Male	19
Female	6

Of which Executive Committee

Male	10
Female	2

Of which Directors

Male	8
Female	3

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Employees

2,498

Sector

Medical Equipment, Supplies & Distribution

More about the company